top-stories
Technology
Soccer-‘I thought it was AI,’ says Wimbledon director of flooding images at stadium
Top Stories
Solvay to cut 68 jobs in Salindres site throughout 2025
Top Stories
Spotify expands AI Playlist feature to new markets including US, Canada
Top Stories
UK employers give joint-lowest pay rises since June 2022, Brightmine says
TUI confirms guidance after strong summer season, shares rise
Date: September 24, 2024
By Andrey Sychev (Reuters) -Europe’s biggest tour operator TUI on Tuesday confirmed its annual guidance and mid-term targets after a strong summer season, sending its shares up in morning trading. Shares in TUI rose 2% by 0735 GMT, hitting their highest level in two months. TUI forecast a 25% increase in operating profit and...
Almost 30,000 suspected mpox cases in Africa this year, WHO says
Date: September 24, 2024
LONDON (Reuters) – Nearly 30,000 suspected mpox cases have been reported in Africa so far this year, most of them in Democratic Republic of Congo where tests have run out, the World Health Organization said on Monday. More than 800 people died of suspected mpox across the continent in that time, the U.N. health...
Novo Nordisk faces US congressional grilling over price of weight loss drugs, FT reports
Date: September 23, 2024
(Reuters) – Novo Nordisk’s chief executive is preparing for a showdown next week with U.S. Senator Bernie Sanders over the high price of blockbuster diabetes and weight loss drugs, as Ozempic falls into the scope of U.S. government price controls, the Financial Times reported on Monday. (Reporting by Disha Mishra in Bengaluru; Editing...
Analysis-SocGen’s CEO Krupa tightens screws on costs as bank’s turnaround plan falls flat
Date: September 20, 2024
By Mathieu Rosemain PARIS (Reuters) – Societe Generale’s CEO Slawomir Krupa is set to turn the screws further on costs as he presses ahead with a turnaround strategy announced a year ago that has so far failed to revive the French bank’s flagging share price. SocGen is one of Europe’s cheapest listed banks, trading at...
EU regulator backs use of Novo’s Wegovy for obesity-related heart condition
Date: September 20, 2024
(Reuters) -The European Medicines Agency backed the use of Novo Nordisk’s popular drug Wegovy to help ease heart failure in people with obesity, the Danish drugmaker said on Thursday. This marks the regulator’s second backing for a use of Wegovy beyond weight loss and further strengthens Novo’s case that the medicine has multiple health benefits....
Analysis-Extreme weather adds to fiscal strains in central Europe
Date: September 20, 2024
By Jan Lopatka, Karol Badohal and Gergely Szakacs PRAGUE/WARSAW (Reuters) – Just a week ago, before deadly floods swept through central Europe, the Czech Republic looked on track to become the first country in the region since COVID-19 to pull its budget deficit firmly below the 3% of GDP cap set by European Union rules....